|
ABHD15 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.214400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.778800E-01 |
| Normal-vs-Stage2 |
9.753000E-01 |
| Normal-vs-Stage3 |
3.044000E-01 |
| Normal-vs-Stage4 |
9.632400E-01 |
| Stage1-vs-Stage2 |
5.876400E-01 |
| Stage1-vs-Stage3 |
8.947600E-02 |
| Stage1-vs-Stage4 |
4.809600E-01 |
| Stage2-vs-Stage3 |
4.624400E-01 |
| Stage2-vs-Stage4 |
9.517800E-01 |
| Stage3-vs-Stage4 |
4.470800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.358800E-01 |
| Normal-vs-AfricanAmerican |
8.899800E-01 |
| Normal-vs-Asian |
2.600600E-01 |
| Caucasian-vs-AfricanAmerican |
9.065200E-01 |
| Caucasian-vs-Asian |
3.471200E-01 |
| AfricanAmerican-vs-Asian |
4.548600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.296200E-02 |
| Normal-vs-Female |
9.756200E-03 |
| Male-vs-Female |
8.32100000000002E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.074060E-02 |
| Normal-vs-Age(41-60Yrs) |
9.990600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.636400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.904600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.259640E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.804300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.770100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.801800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.437000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.629000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.939800E-01 |
| Normal-vs-Grade 2 |
6.780000E-01 |
| Normal-vs-Grade 3 |
6.614600E-01 |
| Normal-vs-Grade 4 |
3.967000E-01 |
| Grade 1-vs-Grade 2 |
4.709600E-01 |
| Grade 1-vs-Grade 3 |
4.441400E-01 |
| Grade 1-vs-Grade 4 |
3.626600E-01 |
| Grade 2-vs-Grade 3 |
9.883800E-01 |
| Grade 2-vs-Grade 4 |
2.662800E-01 |
| Grade 3-vs-Grade 4 |
2.566200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.084200E-02 |
| Normal-vs-ccB subtype |
1.730010E-01 |
| ccA subtype-vs-ccB subtype |
2.942900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.604200E-01 |
| Normal-vs-N1 |
6.486000E-01 |
| N0-vs-N1 |
9.365000E-01 |
|
|
